The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Syundyukova E.G.

South Ural State Medical University

Chulanova Yu.S.

Clinic of the South-Ural State Medical University

Sashenkov S.L.

South Ural State Medical University

Medvedev B.I.

South Ural State Medical University

Uzlova T.V.

South Ural State Medical University

Placenta previa and placenta accreta: questions of diagnosing and obstetric management

Authors:

Syundyukova E.G., Chulanova Yu.S., Sashenkov S.L., Medvedev B.I., Uzlova T.V.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2022;22(3): 12‑20

DOI: 10.17116/rosakush20222203112

Read: 5231 times

Download PDF (RU)
Contact the author
Table of contents

PLACENTA PREVIA AND PLACENTA ACCRETA: QUESTIONS OF DIAGNOSING AND OBSTETRIC MANAGEMENT
PLACENTA PREVIA AND PLACENTA ACCRETA: QUESTIONS OF DIAGNOSING AND OBSTETRIC MANAGEMENT

To cite this article:

Syundyukova EG, Chulanova YuS, Sashenkov SL, Medvedev BI, Uzlova TV. Placenta previa and placenta accreta: questions of diagnosing and obstetric management. Russian Bulletin of Obstetrician-Gynecologist. 2022;22(3):12‑20. (In Russ.)
https://doi.org/10.17116/rosakush20222203112

 
Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

OBJECTIVE OF THE STUDY

To conduct a systematic analysis of the data of modern Russian and foreign literature devoted to epidemiology, modern methods of diagnosis and therapy of placenta previa and placenta accreta.

MATERIAL AND METHODS

The study included data from domestic and foreign literature sources published over the past 10 years.

RESULTS

Placenta previa, especially invasive forms (placenta accreta spectrum PAS), is one of the leading causes of massive obstetric hemorrhage. The etiology of abnormal placentation is unknown. The main risk factor for placental ingrowth remains a scar of the uterus after cesarean section, therefore, measures to reduce the frequency of operative delivery are an actual trend. Ultrasound examination is considered an effective method of prenatal diagnosis of placenta previa and placenta accreta, but there is a wide heterogeneity of terminology and conclusions of specialists. Histopathological examination remains the gold standard for detecting PAS, but there are no generally accepted morphological criteria for accurate gradation of the degree of villi invasion. There are no consensus on the optimal timing of delivery, the use of conservative methods of therapy, the use of specialized multidisciplinary teams to improve the outcomes with placenta accreta.

CONCLUSION

Large randomized prospective studies are needed to develop standardized protocols for the ante-and postnatal diagnosis of placental abnormalities, to determine the safety and effectiveness of various methods of therapy for placenta accreta with detailed clinical and histomorphological data.

Keywords:

placenta previa and placenta accreta

Authors:

Syundyukova E.G.

South Ural State Medical University

Chulanova Yu.S.

Clinic of the South-Ural State Medical University

Sashenkov S.L.

South Ural State Medical University

Medvedev B.I.

South Ural State Medical University

Uzlova T.V.

South Ural State Medical University

Received:

17.09.2021

Accepted:

21.10.2021

Close metadata

References:

  1. Barinov SV, Tirskaya YuI, Medyannikova IV, Zhilin AV, Shavkun IA, Shamina IV. A method for stopping postpartum bleeding by applying a hemostatic external uterine assembly supra-placental suture. Rossiiskii vestnik akushera-ginekologa. 2017;17:1:53-61. (In Russ.). https://doi.org/10.17116/rosakush201717153-61
  2. Shmakov RG, Pirogova MM, Vasil’chenko ON, Chupry’nin VD, Ezhova LS. Surgical tactics for placental ingrowth with different depth of invasion. Akusherstvo i ginekologiya. 2020;1:78-82. (In Russ.). https://doi.org/10.18565/aig.2020.1.78-82
  3. Jauniaux E, Hussein AM, Fox KA, Collins SL. New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2019;61:75-88.  https://doi.org/10.1016/j.bpobgyn.2019.04.006
  4. Anderson-Bagga FM, Sze A. Placenta Previa. 2020 Jun 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. PMID: 30969640. Bookshelf ID: NBK539818.
  5. Fan D, Xia Q, Liu L, Wu S, Tian G, Wang W, Wu S, Guo X, Liu Z. The incidence of postpartum hemorrhage in pregnant women with placenta previa: a systematic review and meta-analysis. PLoS One. 2017;12:1:e0170194. https://doi.org/10.1371/journal.pone.0170194
  6. Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217:27-36.  https://doi.org/10.1016/j.ajog.2017.02.050
  7. Jauniaux E, Ayres-de-Campos D. FIGO placenta accreta diagnosis and management expert consensus panel. FIGO consensus guidelines on placenta accreta spectrum disorders: introduction. Int J Gynaecol Obstet. 2018;140:261-264.  https://doi.org/10.1002/ijgo.12406
  8. Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, Dornan S, Jurkovic D, Kayem G, Kingdom J, Silver R, Sentilhes L; Royal College of Obstetricians and Gynaecologists. Placenta praevia and placenta accreta: diagnosis and management: Green-top Guideline No. 27a. BJOG. 2019;126:1-48.  https://doi.org/10.1111/1471-0528.15306
  9. Obstetric Care Consensus No. 7 Summary: Placenta Accreta Spectrum. Obstet Gynecol. 2018;132:1519-1521. https://doi.org/10.1097/AOG.0000000000002984
  10. Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med. 2018;378:16:1529-1536. https://doi.org/10.1056/NEJMcp1709324
  11. Nieto-Calvache AJ, Palacios-Jaraquemada JM, Osanan G, Cortes-Charry R, Aryananda RA, Bangal VB, Slaoui A, Abbas AM, Akaba GO, Joshua ZN, Vergara Galliadi LM, Nieto-Calvache AS, Sanín-Blair JE, Burgos-Luna JM; Latin American group for the study of placenta accreta spectrum. Lack of experience is a main cause of maternal death in placenta accreta spectrum patients. Acta Obstet Gynecol Scand. 2021;100:8:1445-1453. https://doi.org/10.1111/aogs.14163
  12. Thurn L, Lindqvist PG, Jakobsson M, Colmorn LB, Klungsoyr K, Bjarnadóttir RI, Tapper AM, Børdahl PE, Gottvall K, Petersen KB, Krebs L, Gissler M, Langhoff-Roos J, Källen K. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2016;123:1348-1355. https://doi.org/10.1111/1471-0528.13547
  13. Buca D, Liberati M, Calì G, Forlani F, Caisutti C, Flacco ME, Manzoli L, Familiari A, Scambia G, D’Antonio F. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;52:304-309.  https://doi.org/10.1002/uog.19070
  14. Martinelli KG, Garcia ÉM, Santos Neto ETD, Gama SGND. Advanced maternal age and its association with placenta praevia and placental abruption: a meta-analysis. Cad Saude Publica. 2018;34:2:e00206116. https://doi.org/10.1590/0102-311X00206116
  15. Findeklee S, Costa SD. Placenta accreta and total placenta previa in the 19th week of pregnancy. Geburtshilfe Frauenheilkd. 2015;75:8:839-843.  https://doi.org/10.1055/s-0035-1557763
  16. Reddy UM, Abuhamad AZ, Levine D, Saade GR, Fetal Imaging Workshop Invited Participants. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. J Ultrasound Med. 2014;33:5:745-757.  https://doi.org/10.7863/ultra.33.5.745
  17. Jansen CHJR, Kastelein AW, Kleinrouweler CE, Van Leeuwen E, De Jong KH, Pajkrt E, Van Noorden CJF. Development of placental abnormalities in location and anatomy. Acta Obstet Gynecol Scand. 2020;99:8:983-993. Epub 2020 Mar 18.  https://doi.org/10.1111/aogs.13834
  18. Xasanov AA. Diagnostics, prevention and organ-preserving methods of delivery of pregnant women with placenta accreta. Kazanskii meditsinskii zhurnal. 2016;97:4:477-485. (In Russ.). https://doi.org/10.17750/KMJ2015-477
  19. Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, Belfort MA, Wright JD. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212:561-568.  https://doi.org/10.1016/j.ajog.2014.11.018
  20. Jauniaux E, Burton GJ. Pathophysiology of placenta accreta spectrum disorders: a review of current findings. Clin Obstet Gynecol. 2018;61:743-754.  https://doi.org/10.1097/GRF.0000000000000392
  21. Milovanov AP, Bushtarev AV, Fokina TV. Features of cytotrophoblastic invasion in complete presentation and placenta ingrowth. Arkhiv patologii. 2017;6:30-35. (In Russ.). https://doi.org/10.17116/patol201779630-35
  22. Macklin PS, McAuliffe J, Pugh CW, Yamamoto A. Hypoxia and HIF pathway in cancer and the placenta. Placenta. 2017;56:8-13.  https://doi.org/10.1016/j.placenta.2017.03.010
  23. Chulkov V, Medvedev B, Syundyukova E, Sashenkov S. Cell renovation markers, apoptotic markers and placental expression of erythropoietin in preeclampsia. Pregnancy Hypertension. 2017;9:48.  https://doi.org/10.1016/j.preghy.2017.07.102
  24. Qian ZD, Weng Y, Wang CF, Huang LL, Zhu XM. Research on the expression of integrin beta3 and leukaemia inhibitory factor in the decidua of women with cesarean scar pregnancy. BMC Pregnancy Childbirth. 2017;17:84.  https://doi.org/10.1186/s12884-017-1270-3
  25. Vahanian SA, Lavery JA, Ananth CV, Vintzileos A. Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. Am J Obstet Gynecol. 2015;213:78‐90.  https://doi.org/10.1016/j.ajog.2015.05.058
  26. Huang M, Li X, Guo P, Yu Z, Xu Y, Wei Z. The abnormal expression of oxytocin receptors in the uterine junctional zone in women with endometriosis. Reprod Biol Endocrinol. 2017;15:1:1.  https://doi.org/10.1186/s12958-016-0220-7
  27. Shobeiri F, Jenabi E. Smoking and placenta previa: a meta‐analysis. J Matern Fetal Neonatal Med. 2017;30:2985-2990. https://doi.org/10.1080/14767058.2016.1271405
  28. Jing L, Wei G, Mengfan S, Yanyan H. Effect of site of placentation on pregnancy outcomes in patients with placenta previa. PLoS One. 2018;13:7:e0200252. https://doi.org/10.1371/journal.pone.0200252
  29. Ahn KH, Lee EH, Cho GJ, Hong SC, Oh MJ, Kim HJ. Anterior placenta previa in the mid-trimester of pregnancy as a risk factor for neonatal respiratory distress syndrome. PLoS One. 2018;13:11:e0207061. https://doi.org/10.1371/journal.pone.0207061
  30. Feng Y, Li XY, Xiao J, Li W, Liu J, Zeng X, Chen X, Chen KY, Fan L, Kang QL, Chen SH. Risk factors and pregnancy outcomes: complete versus incomplete placenta previa in mid-pregnancy. Curr Med Sci. 2018;38:4:597-601.  https://doi.org/10.1007/s11596-018-1919-9
  31. Jansen CHJR, Kleinrouweler CE, van Leeuwen L, Ruiter L, Limpens J, van Wely M, Mol BW, Pajkrt E. Final outcome of a second trimester low‐positioned placenta: a systematic review and meta‐analysis. Eur J Obstet Gynecol Reprod Biol. 2019;240:197-204.  https://doi.org/10.1016/j.ejogrb.2019.06.020
  32. Boerma T, Ronsmans C, Melesse DY, Barros AJD, Barros FC, Juan L, Moller AB, Say L, Hosseinpoor AR, Yi M, de Lyra Rabello Neto D, Temmerman M. Global epidemiology of use of and disparities in caesarean sections. Lancet. 2018;392:1341-1348. https://doi.org/10.1016/S0140-6736(18)31928-7
  33. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O’Sullivan MJ, Sibai B, Langer O, Thorp JM, Ramin SM, Mercer BM; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107:1226-1232. https://doi.org/10.1097/01.AOG.0000219750.79480.84
  34. Baldwin HJ, Patterson JA, Nippita TA, Torvaldsen S, Ibiebele I, Simpson JM, Ford JB. Antecedents of abnormally invasive placenta in primiparous women: risk associated with gynecologic procedures. Obstet Gynecol. 2018;131:227-233.  https://doi.org/10.1097/AOG.0000000000002434
  35. Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219:2‐16.  https://doi.org/10.1016/j.ajog.2018.09.042
  36. Sharma S, Godbole G, Modi D. Decidual control of trophoblast invasion. Am J Reprod Immunol. 2016;75:341-350.  https://doi.org/10.1111/aji.12466
  37. Plaks V, Rinkenberger J, Dai J, Flannery M, Sund M, Kanasaki K, Ni W, Kalluri R, Werb Z. Matrix metalloproteinase‐9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proc Natl Acad Sci USA. 2013;110:11109-11114. https://doi.org/10.1073/pnas.1309561110
  38. Carlino C, Rippo MR, Lazzarini R, Monsurrò V, Morrone S, Angelini S, Trotta E, Stabile H, Bastianelli C, Albertini MC, Olivieri F, Procopio A, Santoni A, Gismondi A. Differential microRNA expression between decidual and peripheral blood natural killer cells in early pregnancy. Hum Reprod. 2018;33:2184-2195. https://doi.org/10.1093/humrep/dey323
  39. Early pregnancy. From prepregnancy preparation to healthy gestation. Ed. by Radzinskii V.E. M.: Mediabyuro Status Praesens; 2018;800. (In Russ.).
  40. Lin TC, Hsiao M. Ghrelin and cancer progression. Biochim Biophys Acta Rev Cancer. 2017;1868:1:51-57.  https://doi.org/10.1016/j.bbcan.2017.02.002
  41. Torregrossa F, Aguennouz M, La Torre D, Sfacteria A, Grasso G. Role of erythropoietin in cerebral glioma: an innovative target in neuro-oncology. World Neurosurg. 2019;131:346-355.  https://doi.org/10.1016/j.wneu.2019.06.221
  42. Medvedev BI, Syundyukova EG, Sashenkov SL. Placental expression of erythropoietin in preeclampsia. Rossiiskii vestnik akushera-ginekologa. 2015;15:1:4-8. (In Russ.). https://doi.org/10.17116/rosakush20151514-8
  43. Zwierzchowska A, Iwan A, Hyc A, Suchońska B, Malejczyk J, Barcz E. Recurrent miscarriage is associated with increased ghrelin mRNA expression in the endometrium — a case-control study. Reprod Biol. 2018;18:1:12-17.  https://doi.org/10.1016/j.repbio.2017.11.003
  44. Akarsu S, Buke B, Göde F, Dirican KE, Başbuğ A, Ceyhan ST, Goktolga U, Akın O, Korkmaz C, Kara C, Zeki Isık A. Association of serum and follicular fluid leptin and ghrelin levels with in vitro fertilization success. Ginekol Pol. 2017;88:9:469-474.  https://doi.org/10.5603/gp.a2017.0086
  45. Wang X, Yang L, Chen Y, Zhang L, Fei H. Ghrelin promotes angiogenesis by activating the Jagged1/Notch2/VEGF pathway in preeclampsia. J Obstet Gynaecol Res. 2021;47:2:486-494.  https://doi.org/10.1111/jog.14555
  46. Zakharov Yu.M. Extrarenal erythropoietin production and its regulation. Rosiiskii fiziologicheskii zhurnal im. I.M. Sechenova. 2015;101:11:1217-1234. (In Russ.).
  47. Shirshev SV, Nekrasova IV, Gorbunova OL, Orlova EG Hormonal regulation of NK cell cytotoxic activity. Dokl Biol Sci. 2017;472:1:28-30.  https://doi.org/10.1134/S0012496617010021
  48. Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol. 2014;31:799-804.  https://doi.org/10.1055/s-0033-1361833
  49. Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, Stefanovic V, Tutschek B, Chantraine F; European Working Group on Abnormally Invasive Placenta (EW-AIP). Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016;47:271-275.  https://doi.org/10.1002/uog.14952
  50. Alfirevic Z, Tang A-W, Collins SL, Robson SC, Palacios-Jaraquemadas, on behalf of the Ad-hoc International AIP Expert group. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP); an international consensus. Ultrasound Obstet Gynecol. 2016;47:276-278.  https://doi.org/10.1002/uog.15810
  51. Jauniaux E, Collins SL, Jurkovic D, Burton GJ Accreta placentation. A systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 2016;215:712-721.  https://doi.org/10.1016/j.ajog.2016.07.044
  52. Familiari A, Liberati M, Lim P, Pagani G, Cali G, Buca D, Manzoli L, Flacco ME, Scambia G, D’antonio F. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97:507-520.  https://doi.org/10.1111/aogs.13258
  53. Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver RM. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol. 2018;218:618.e1-618.e7.  https://doi.org/10.1016/j.ajog.2018.03.013
  54. Panaiotova J, Tokunaka M, Krajewska K, Zosmer N, Nicolaides KH. Screening for morbidly adherent placenta in early pregnancy. Ultrasound Obstet Gynecol. 2019;53:101-106.  https://doi.org/10.1002/uog.20104
  55. Melcer Y, Jauniaux E, Maymon S, Tsviban A, Pekar-Zlotin M, Betser M, Maymon R. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. Am J Obstet Gynecol. 2018;218:443.e1-443.  https://doi.org/10.1016/j.ajog.2018.01.017
  56. Lukashevich AA, Aksenenko VA, Milovanov AP, Dubovoi AA, Nezhdanov IG, Mozheiko LN. Prediction of placental ingrowth during pregnancy based on the determination of serum markers of pathology. Doktor.Ru. 2020;19:1:6-11. (In Russ.). https://doi.org/10.31550/1727-2378-2020-19-1-6-11
  57. ACOG Committee Opinion No. 764: Medically Indicated Late-Preterm and Early-Term Deliveries. Obstet Gynecol. 2019;133:2:151-155.  https://doi.org/10.1097/AOG.0000000000003083
  58. Jansen C, de Mooij YM, Blomaard CM, Derks JB, van Leeuwen E, Limpens J, Schuit E, Mol BW, Pajkrt E. Vaginal delivery in women with a low-lying placenta: a systematic review and meta-analysis. BJOG. 2019;126:9:1118-1126. https://doi.org/10.1111/1471-0528.15622
  59. Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol. 2015;126:3:654-668.  https://doi.org/10.1097/AOG.0000000000001005
  60. Markley JC, Farber MK, Perlman NC, Carusi DA. Neuraxial anesthesia during cesarean delivery for placenta previa with suspected morbidly adherent placenta: a retrospective analysis. Anesth Analg. 2018;127:4:930-938.  https://doi.org/10.1213/ANE.0000000000003314
  61. Ryu JM, Choi YS, Bae JY. Bleeding control using intrauterine continuous running suture during cesarean section in pregnant women with placenta previa. Arch Gynecol Obstet. 2019;299:1:135-139.  https://doi.org/10.1007/s00404-018-4957-4
  62. Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA. FIGO placenta accreta diagnosis and management expert consensus panel. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management. Int J Gynaecol Obstet. 2018;140:281-290.  https://doi.org/10.1002/ijgo.12409
  63. Hussein AM, Kamel A, Raslan A, Dakhly DMR, Abdelhafeez A, Nabil M, Momtaz M. Modified cesarean hysterectomy technique for management of cases of placenta increta and percreta at a tertiary referral hospital in Egypt. Arch Gynecol Obstet. 2019;299:3:695-702.  https://doi.org/10.1007/s00404-018-5027-7
  64. Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E. FIGO placenta accreta diagnosis and management expert consensus panel. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet. 2018;140:291-298.  https://doi.org/10.1002/ijgo.12410
  65. Barinov SV, Medyannikova IV, Tirskaya YuI, Shamina IV, Shavkun IA. Placenta increment in the area of the uterine scar after myomectomy: a combined approach for surgical delivery. Rossiiskii vestnik akushera-ginekologa. 2018;18:2:88-91. (In Russ.). https://doi.org/10.17116/rosakush201818288-91
  66. Wolf MF, Maymon S, Shnaider O, Singer-Jordan J, Maymon R, Bornstein J, Tovbin J. Two approaches for placenta accreta spectrum: B-lynch suture versus pelvic artery endovascular balloon. J Matern Fetal Neonatal Med. 2020;33:16:2711-2717. https://doi.org/10.1080/14767058.2018.1558199
  67. Ratiu AC, Crisan DC. A prospective evaluation and management of different types of placenta praevia using parallel vertical compression suture to preserve uterus. Medicine (Baltimore). 2018;97:e13253. https://doi.org/10.1097/MD.0000000000013253
  68. D’Antonio F, Iacovelli A, Liberati M, Leombroni M, Murgano D, Cali G, Khalil A, Flacco ME, Scutiero G, Iannone P, Scambia G, Manzoli L, Greco P. Role of interventional radiology in pregnancies complicated by placenta accreta spectrum disorders: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;53:6:743-751.  https://doi.org/10.1002/uog.20131
  69. Hussein AM, Dakhly DMR, Raslan AN, Kamel A, Abdel Hafeez A, Moussa M, Hosny AS, Momtaz M. The role of prophylactic internal iliac artery ligation in abnormally invasive placenta undergoing caesarean hysterectomy: a randomized control trial. J Matern Fetal Neonatal Med. 2019;32:20:3386-3392. https://doi.org/10.1080/14767058.2018.1463986
  70. Shamshirsaz AA, Fox KA, Erfani H, Clark SL, Salmanian B, Baker BW, Coburn M, Shamshirsaz AA, Bateni ZH, Espinoza J, Nassr AA, Popek EJ, Hui SK, Teruya J, Tung CS, Jones JA, Rac M, Dildy GA, Belfort MA. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol. 2017;216:612.e1-612.e5.  https://doi.org/10.1016/j.ajog.2017.02.016. E
  71. Bartels HC, Rogers AC, O’Brien D, McVey R, Walsh J, Brennan DJ. Association of implementing a multidisciplinary team approach in the management of morbidly adherent placenta with maternal morbidity and mortality. Obstet Gynecol. 2018;132:1167-1176. https://doi.org/10.1097/AOG.0000000000002865
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.